Delivery Order SPE2DB24D2205-SPE2DB24FDXGE

Award Date 7/23/24
Potential Completion Date 8/13/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OFEV 150 MG CAPSULE 60S. The firm-fixed-price contract is valued at $15,811.12 and has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,905.56 contract is for the supply of OFEV 150 MG CAPSULE 60S, a prescription medication. The contract is a Firm Fixed Price type with an ultimate completion date of August 20, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,905.56 delivery order contract is for the supply of OFEV 150 MG CAPSULE 60S, a prescription medication. The contract has an ultimate completion date of September 16, 2024 and is a firm fixed-price contract type. This award is likely part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of OFEV 150 MG CAPSULE 60S. The contract has a ceiling value of $8,590.58 and is a firm fixed-price delivery order with a period of performance through March 4, 2025. The contract was awarded on February 10, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $8,590.58 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has an ultimate completion date of January 24, 2025, is for the supply of OFEV 150 MG CAPSULE 60S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $15,811.12 firm-fixed-price contract is for the supply of OFEV 150 MG capsules. There is no set-aside designation. The order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which provides a wide range of essential pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $7,905.56 with a completion date of December 5, 2024. The contract is for the supply of OFEV 150 MG capsules, a pharmaceutical product. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant IDC with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $16,378.86, is for the delivery of OFEV 100 MG CAPSULE 60S, a medication, and has a completion date of January 22, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of OFEV 100 MG capsules. The contract has a ceiling value of $7,915.84 and a completion date of September 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,630.28 and a completion date of January 29, 2025. It is a firm-fixed-price contract for the delivery of OFEV 100 MG CAPSULE 60S, a pharmaceutical product. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDXGE
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of OFEV 150 MG capsules. The contract, valued at $7,905.56, has a firm fixed price and an ultimate completion date of August 13, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award enables the DLA to efficiently procure essential pharmaceutical products from AmerisourceBergen to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 10/22/24, 9:06 AM